Stay updated on Pembrolizumab Combination in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combination in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Combination in Advanced Melanoma Clinical Trial page
- Check2 days agoChange DetectedUpdates the page’s revision/version label from **v3.5.2** to **v3.5.3** without changing the study record content.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; this appears to be a minor patch with no changes to study content or user-facing features.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Revision: v3.4.2 and removed the older revision tag v3.4.1 and outdated government funding/status notices from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedA government funding notice about potential delays and NIH operating status was added, and the site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Combination in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combination in Advanced Melanoma Clinical Trial page.